TIZIMLI KASALLIKLARDA BUYRAKLARNI ZARARLANISHI

Authors

  • Tuxtamishev Rustam Bultakovich Samarqand Davlat Tibbiyot Universiteti Bolalar ichki kasalliklari propedevtikasi kafedrasi bolalar nefrologiyasi gemodializ bilan yo'nalishi klinik ordinatori
  • Abduvaliyev Zuhriddin Eshmurodovich Samarqand Davlat Tibbiyot Universiteti Bolalar ichki kasalliklari propedevtikasi kafedrasi bolalar nefrologiyasi gemodializ bilan yo'nalishi klinik ordinatori
  • Nazarov Dostonjon Komilovich Samarqand Davlat Tibbiyot Universiteti Bolalar ichki kasalliklari propedevtikasi kafedrasi bolalar nefrologiyasi gemodializ bilan yo'nalishi klinik ordinatori

Keywords:

Tizimli kasalliklar, buyrak zararlanishi, nefropatiya, autoimmun kasalliklar, sistemik lupus eritematozus, revmatoid artrit, glomerulonefrit, interstitsial nefrit, klinik ko‘rinish, diagnostika, patofiziologiya, dori-darmon yondashuvi, kasallik prognozi, nefrologik asoratlar.

Abstract

Ushbu maqola tizimli kasalliklarda buyraklarning zararlanishi, uning patofiziologiyasi, klinik ko‘rinishlari, diagnostikasi va davolash strategiyalarini chuqur o‘rganishga bag‘ishlangan. Tizimli kasalliklar, jumladan autoimmun patologiyalar (masalan, sistemik lupus eritematozus, revmatoid artrit) va yallig‘lanish bilan bog‘liq kasalliklar, buyraklarda turli darajadagi morfologik va funksional o‘zgarishlarni keltirib chiqaradi. Maqolada buyrak zararlanishi mexanizmlari, glomerular va interstitsial shikastlanish turlari, klinik belgilari, laborator va instrumental diagnostika usullari tahlil qilinadi. Shuningdek, buyrak disfunksiyasini aniqlash, kasallikning og‘irligini baholash va samarali davolash yondashuvlarini tanlash muhimligi ta’kidlanadi. Tadqiqot natijalari tizimli kasalliklarda buyrakni vaqtida himoya qilish va asoratlarni kamaytirish uchun erta tashxis va individual davolash strategiyalarining ahamiyatini ko‘rsatadi.

References

1. Hahn, B. H., McMahon, M. A., Wilkinson, A., et al. (2012). American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care & Research, 64(6), 797–808.

2. Costenbader, K. H., & Karlson, E. W. (2006). Autoimmune disease and renal involvement. Nature Reviews Nephrology, 2(6), 294–304.

3. Tektonidou, M. G., Dasgupta, A., Ward, M. M. (2016). Long-term outcomes in systemic autoimmune diseases affecting the kidney. Annals of the Rheumatic Diseases, 75(5), 857–864.

4. Hogan, S. L., & Jennette, J. C. (2001). Systemic autoimmune diseases and glomerular disease. Kidney International, 59(5), 1861–1873.

5. D’Cruz, D. P., Khamashta, M. A., Hughes, G. R. (2007). Systemic lupus erythematosus. Lancet, 369(9561), 587–596.

6. Hahn, B. H., & Tsao, B. P. (2005). Immunopathogenesis of lupus nephritis. Current Opinion in Rheumatology, 17(5), 537–545.

7. Al Sawah, S., Gladman, D. D., Urowitz, M. B., et al. (2015). Renal involvement in systemic autoimmune diseases. Lupus, 24(12), 1293–1302.

8. Weening, J. J., D’Agati, V. D., Schwartz, M. M., et al. (2004). Classification of glomerulonephritis in systemic lupus erythematosus. Kidney International, 65(2), 521–530.

Downloads

Published

2026-02-09

How to Cite

TIZIMLI KASALLIKLARDA BUYRAKLARNI ZARARLANISHI. (2026). FAN, TA’LIM, TEXNOLOGIYA VA ISHLAB CHIQARISH INTEGRATSIYASI ASOSIDA RIVOJLANISH ISTIQBOLLARI, 3(2), 10-14. https://universalpublishings.com/index.php/fan/article/view/16631